Researchers Find Genes Responsible for Colorectal-Cancer Recurrence
For decades, patients diagnosed with early-stage colorectal cancer believed they were relatively fortunate. "At least it's early stage," some remarked. The view was, "The disease has been caught early; treatment with surgical removal of the tumor alone will suffice; I won’t need adjuvant chemotherapy; and my prospects for beating the disease are very good." This view was driven by the assumption that all early-stage colorectal cancer tumors were low-risk for recurrence.